Increased bone mineral density in aged rats with spontaneous mammary dysplasia

In Vivo

Volumn 21, Issue 4, 2007, Pages 583-586

  Kawaguchi, Hiroaki ^a   Umekita, Yoshihisa ^a   Souda, Masakazu ^a   Gejima, Kentaro ^a   Kawashima, Hideo ^a   Maeda, Hiroshi ^b   Miyajima, Hiroaki ^b   Nagata, Ryoichi ^b   Yoshida, Hiroki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

Bone mineral density (BMD); DXA; Mammary dysplasia; Mammary tumor; Rat

Indexed keywords

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BREAST DYSPLASIA; BREAST TUMOR; CONTROLLED STUDY; CORPUS LUTEUM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; LUMBAR VERTEBRA; NONHUMAN; OVARY FOLLICLE; RAT;

EID: 34547767568     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E and Mallet D: Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues 15: 97-108, 2005.
2. Ganry O, Tramier B, Fardellone P, Raverdy N and Dubreuil A: High bone-mass density as a marker for breast cancer in postmenopausal women. Breast 10: 313-317, 2001.
3. Warming L, Ravn P and Christiansen C: Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. Maturitas 50: 78-85, 2005.
4. Rosenberg AE: Bones, joints, and soft tissue tumors. In: Robbins and Cotran Pathologic Basis of Disease, 7th ed., Kumar V, Abbas AK, Fausto N (eds.). Philadelphia, Elsevier Saunders, pp. 1282-1284, 2005.
5. Cho CH and Nuttall ME: Therapeutic potential of oestrogen receptor ligands in development for osteoporosis. Expert Opin Emerg Drugs 6: 137-154, 2001.
6. Kudachadkar R and O'Regan RM: Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer. CA Cancer J Clin 55: 145-163, 2005.
7. Modugno F, Kip KE, Cochrane B, Kuller L, Klug TL, Rohan TE, Chlebowski RT, Lasser N and Stefanick ML: Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer. Int J Cancer 118: 1292-1301, 2006.
8. Magnusson CMK, Roddam AW, Pike MC, Chilvers C, Crossley B, Hermon C, McPherson K, Peto J, Vessey M and Beral V: Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women. Br J Cancer 93: 817-824, 2005.
9. Mashiba T, Tanizawa T, Takahashi HE, Takano Y, Nishida S, Mori S and Norimatsu H: Effects of single and concurrent intermittent administration of human parathyroid hormone and bisphosphonate cimadronate on bone mineral densities of femur in ovariectomized rats. J Bone Miner Metab 13: 17-22, 1995.
10. Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S and Takahashi HE: Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats. J Bone Miner Res 11: 169-177, 1996.
11. Mashiba T, Tanizawa T, Takano Y, Takahashi HE, Mori S and Norimatsu H: A histomorphometric study on effects of single and concurrent intermittent administration of human PTH (1-34) and bisphosphonate cimadronate on tibial metaphysis in ovariectomized rats. Bone 17: 273S-278S, 1995.
12. Ke HZ, Simmons HA, Pirie CM, Crawford DT and Thompson DD: Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 136: 2435-2441, 1995.
13. Yoshida H and Huggins C: Effects of neonatally administered testosterone propionate on the development of target organs of sex hormones and the induction of mammary carcinomas by 7, 12-dimethylbenz[a]anthracene in female Sprague-Dawley rats. Exp Anita 30: 303-305, 1981.
14. Yoshida H, Kadota A and Fukunishi R: Pathology of early lesions of mammary carcinoma and mammary dysplasia induced by 7,12-dimethylbenz[a]anthracene in the neonatally androgenized Sprague-Dawley female rats. Virchows Arch B Cell Pathol Incl Mol Pathol 34: 33-41, 1980.
15. Yoshida H, Kadota A, Fukunishi R and Matsumoto K: Induction of mammary dysplasia and mammary carcinoma in neonatally androgenized female rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 64: 1105-1112, 1980.
16. Yoshida H, Fukunishi R, Kato Y and Matsumoto K: Progression-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats. J Natl Cancer Inst 65: 823-828, 1980.
17. Yoshida H and Fukunishi R: Effects of sex steroids on the development of 7,12-dimethylbenz[a]anthracene -induced mammary dysplasia in neonatally androgenized female rats. Gann 72: 315-317, 1981.
18. Kawaguchi H, Sato K, Omachi K, Funato M, Nagata R and Yoshida H: Effects of high doses of 17β-estradiol and ovariectomy on 7,12-dimethylbenz[a]anthracene -induced mammary carcinomas and dysplasias in neonatally androgenized female Sprague-Dawley rats. J Toxicol Pathol 13: 77-85, 2000.
19. Baker DEJ: reproduction and breeding. In: The laboratory rat. Baler HJ, Lindsey JR and Weisbroth SH (eds.). New York, Academic Press Inc., pp. 154-166, 1979.
20. Lu KH, Hopper BR, Vargo TM and Yen SSC: Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive stages. Biol Reprod 21: 193-203, 1979.
21. Nimrod A and Ryan KJ: Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 40: 367-372, 1975.
22. Siiteri PK: Adipose tissue as a source of hormones. Am J Clin Nutr 45: 277-282, 1987.
23. Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86: 225-230, 2003.
24. Zhao H, Tian Z, Hao J and Chen B: Extragonadal aromatization increases with time after ovariectomy in rats. Reprod Biol Endocrinol 3: 6, 2005.